Literature DB >> 23863945

Need for standardising adverse event reporting in testosterone trials.

Shehzad Basaria1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23863945     DOI： 10.1136/eb-2013-101402

Source DB:  PubMed          Journal:  Evid Based Med        ISSN： 1356-5524


× No keyword cloud information.
  4 in total

1.  Risk of Myocardial Infarction in Older Men Receiving Testosterone Therapy.

Authors:  Jacques Baillargeon; Randall J Urban; Yong-Fang Kuo; Kenneth J Ottenbacher; Mukaila A Raji; Fei Du; Yu-Li Lin; James S Goodwin
Journal:  Ann Pharmacother       Date:  2014-07-02       Impact factor: 3.154

2.  Longitudinal Changes Over 10 Years in Free Testosterone Among HIV-Infected and HIV-Uninfected Men.

Authors:  Laurence Slama; Lisa P Jacobson; Xiuhong Li; Frank J Palella; Joseph B Margolick; Lawrence A Kingsley; Dorothy J Wiley; Gilles Pialoux; Adrian S Dobs; Todd T Brown
Journal:  J Acquir Immune Defic Syndr       Date:  2016-01-01       Impact factor: 3.731

Review 3.  Testosterone replacement therapy and cardiovascular risk.

Authors:  Thiago Gagliano-Jucá; Shehzad Basaria
Journal:  Nat Rev Cardiol       Date:  2019-09       Impact factor: 32.419

Review 4.  Trials of testosterone replacement reporting cardiovascular adverse events.

Authors:  Thiago Gagliano-Jucá; Shehzad Basaria
Journal:  Asian J Androl       Date:  2018 Mar-Apr       Impact factor: 3.285
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.